Inhibition of the monkey corpus luteum with 15-methyl prostaglandins.
The corpus luteum inhibiting properties of eighteen 15-methyl prostaglandin analogs were determined in the rhesus monkey during concomitant stimulation of the corpus luteum with chorionic gonadotropin. The methyl ester of (15S)-15-methyl PGF2 alpha (15M-PGF2 alpha, 12.5 mg/monkey) lowered serum progesterone to 12% of pretreatment values within 24 hours, however progesterone returned to normal limits within 48 hours. Elongation of the top side-chain by two carbons (2a,2b-dihomo-15M-PGF2 alpha methyl ester, 13 mg/monkey), substitution of a hydroxymethyl group at carbon 1 (2-decarboxy-2-hydroxymethyl-15M-PGF2 alpha, 12 mg/monkey), or the formation of the carbon 1 amide (15M-PGF2 alpha amide, 12.5 mg/monkey) improved the inhibitory activity of 15M-PGF2 alpha; serum progesterone for these 3 analogs was depressed to 15-30% of pretreatment levels within 24 hours, and did not return to control values. Luteal function was not inhibited (12 or more mg/monkey) when the 15-methyl group was placed in the R configuration, the top side chain was shortened by two carbons, an amino group was substituted for carbon 1, the 5-oxa modification was added, or the 1,9-lactone was formed. Some other modifications of 15M-PGF2 alpha were also inactive, although not all were tested at equivalent doses: 2,2-difluoro; 4,5-cis-didehydro; 9,11-dideoxy-9 alpha, 11 alpha-dichloro; 11-deoxy; 17-phenyl; 1,15-lactone; and the p-benzamidophenyl ester of 2a,2b-dihomo-15M-PGF2 alpha. (15S)-15-Methyl PGE2 methyl ester (1 mg/monkey) depressed serum progesterone concentrations to 42% of pretreatment values within 24 hours; 2a,2b-dihomo-11-deoxy-(15S)-15-methyl PGE2 methyl ester was inactive (5 mg/monkey). A corpus luteum inhibiting action of certain 15-methyl prostaglandins can be demonstrated in the rhesus monkey.
D000818:Animals; D001101:Arbaprostil / Q000031:analogs & derivatives / Q000494:pharmacology*; D002260:Carboprost / Q000031:analogs & derivatives / Q000494:pharmacology*; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects*; D005260:Female; D008253:Macaca mulatta; D008598:Menstruation / Q000187:drug effects; D011374:Progesterone / Q000097:blood*; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D006063:Chorionic Gonadotropin; D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D011374:Progesterone; D002260:Carboprost; D001101:Arbaprostil